Xarelto 20 MG tablet 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2YB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,591
Award facts
- Contract value 100% obligated
- $39,591.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,591.48 firm fixed-price delivery order to AmerSourceBergen Drug Corp for 1,000 tablets of Xarelto 20 mg, an anticoagulant medication used for stroke prevention and blood clot treatment. The order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a non-competitive award executed under an existing Indefinite Delivery Contract. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc., which rebranded from AmerSourceBergen in 2023. This delivery order was not designated as a set-aside contract and falls under the company's established relationship with DLA for pharmaceutical procurement supporting military healthcare systems.
This task order is issued under Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support global military healthcare operations. The contract vehicle enables efficient fulfillment of federal medical procurement needs across therapeutic domains, supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The rapid completion timeline reflects the routine procurement process for essential pharmaceutical inventory replenishment within the Defense Health Agency's supply chain.
Quick answers
Who was awarded contract SPE2DR26FG2YB?
SPE2DR26FG2YB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FG2YB worth?
The government has obligated $39,591 on SPE2DR26FG2YB.
Is contract SPE2DR26FG2YB an order under another contract?
Yes. SPE2DR26FG2YB is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2YB competed?
The extent of competition for SPE2DR26FG2YB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award